Pontificia Universidad Católica de Chile-ko ikertzaileekin lankidetzan egindako argitalpenak (12)

2022

  1. Pharmacogene Variants Associated with Liver Transplant in a Twelve-Year Clinical Follow-Up

    Pharmaceutics, Vol. 14, Núm. 2

2018

  1. Impact of NADPH oxidase functional polymorphisms in acute myeloid leukemia induction chemotherapy

    Pharmacogenomics Journal, Vol. 18, Núm. 2, pp. 301-307

  2. Personalized medicine into health national services: Barriers and potentialities

    Drug Metabolism and Personalized Therapy, Vol. 33, Núm. 4, pp. 159-163

2017

  1. Impact of ABC single nucleotide polymorphisms upon the efficacy and toxicity of induction chemotherapy in acute myeloid leukemia

    Leukemia and Lymphoma, Vol. 58, Núm. 5, pp. 1197-1206

  2. Influence of cytarabine metabolic pathway polymorphisms in acute myeloid leukemia induction treatment

    Leukemia and Lymphoma, Vol. 58, Núm. 12, pp. 2880-2894

2016

  1. A systematic review and meta-analysis of the impact of WT1 polymorphism rs16754 in the effectiveness of standard chemotherapy in patients with acute myeloid leukemia

    Pharmacogenomics Journal, Vol. 16, Núm. 1, pp. 30-40

  2. Positive impact of ABCB1 polymorphisms in overall survival and complete remission in acute myeloid leukemia: A systematic review and meta-analysis

    Pharmacogenomics Journal

2015

  1. Association of SNPs with the efficacy and safety of immunosuppressant therapy after heart transplantation

    Pharmacogenomics, Vol. 16, Núm. 9, pp. 971-979

  2. Effect of CYP3A5∗3 on kidney transplant recipients treated with tacrolimus: A systematic review and meta-analysis of observational studies

    Pharmacogenomics Journal, Vol. 15, Núm. 1, pp. 38-48

  3. Influence of ABCB1 polymorphisms upon the effectiveness of standard treatment for acute myeloid leukemia: A systematic review and meta-analysis of observational studies

    Pharmacogenomics Journal, Vol. 15, Núm. 2, pp. 109-118

2014

  1. SNPs and taxane toxicity in breast cancer patients

    Pharmacogenomics, Vol. 15, Núm. 15, pp. 1845-1858

2013

  1. Meta-analysis and systematic review of the effect of the donor and recipient CYP3A5 6986A>G genotype on tacrolimus dose requirements in liver transplantation

    Pharmacogenetics and Genomics, Vol. 23, Núm. 10, pp. 509-517